Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction, EMCDDA
Autor institucional: EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTIONIdioma: Inglês.Publicação: Luxembourg : Office for Official Publications of the European Communities, 1999Descrição física: 94 p.; 21 cmISBN: 929168063XAssunto: 103892 | 410454 | 320915 | 229150 | 321506Resumo: Foreword. Abbreviations. Introduction. Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Joint action concerning the information exchange, risk assessment and the control of new synthetic drugs. EMCDDA-EDU progress report on the joint action on new synthetic drugs. The pharmacotoxicology and neuropsychology of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB). Sociological and criminological evidence on the risks of MBDB. Public health risks of MBDB: epidemiological evidence. References. Participants in the risk-assessment process.| Item type | Current location | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Monografias | Biblioteca da Polícia Judiciária | PJ19.D.87 (Browse shelf) | PJ28088 | Available | PJ128088 |
Foreword. Abbreviations. Introduction. Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Joint action concerning the information exchange, risk assessment and the control of new synthetic drugs. EMCDDA-EDU progress report on the joint action on new synthetic drugs. The pharmacotoxicology and neuropsychology of N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB). Sociological and criminological evidence on the risks of MBDB. Public health risks of MBDB: epidemiological evidence. References. Participants in the risk-assessment process.
There are no comments for this item.